Boston Scientific Corporation (BSX)

Boston Scientific Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	18,494	16,747	14,240	12,682	11,888	9,913
Revenue Growth (YoY)	21.44%	17.61%	12.29%	6.68%	19.92%	-7.66%
Cost of Revenue	5,910	5,290	4,391	4,003	3,760	3,242
Gross Profit	12,584	11,457	9,849	8,679	8,128	6,671
Selling, General & Admin	6,486	5,984	5,190	4,520	4,359	3,787
Research & Development	1,835	1,615	1,414	1,323	1,204	1,143
Operating Expenses	9,194	8,455	7,432	6,646	6,304	5,719
Operating Income	3,390	3,002	2,417	2,033	1,824	952
Interest Expense	-331	-305	-265	-470	-341	-361
Interest & Investment Income	107	107	22	10	4	3
Currency Exchange Gain (Loss)	-11	-16	-41	-31	-27	-32
Other Non Operating Income (Expenses)	379	-30	-15	-14	-7	6
EBT Excluding Unusual Items	3,534	2,758	2,118	1,528	1,453	568
Merger & Restructuring Charges	-104	-16	-69	-24	-40	-179
Impairment of Goodwill	-	-	-	-	-	-73
Gain (Loss) on Sale of Investments	-67	-79	-59	-1	250	383
Gain (Loss) on Sale of Assets	-	-	-	-22	78	-
Asset Writedown	-156	-386	-58	-132	-370	-452
Legal Settlements	-	-	111	-173	-430	-278
Other Unusual Items	-207	5	-58	-35	136	-49
Pretax Income	3,000	2,282	1,985	1,141	1,077	-80
Income Tax Expense	502	436	393	443	36	2
Earnings From Continuing Operations	2,498	1,846	1,592	698	1,041	-82
Minority Interest in Earnings	8	8	1	-	-	-
Net Income	2,506	1,854	1,593	698	1,041	-82
Preferred Dividends & Other Adjustments	1	1	23	56	56	33
Net Income to Common	2,505	1,853	1,570	642	985	-115
Net Income Growth	37.09%	16.38%	128.22%	-32.95%	-	-
Shares Outstanding (Basic)	1,476	1,472	1,453	1,431	1,422	1,417
Shares Outstanding (Diluted)	1,491	1,486	1,464	1,440	1,434	1,417
Shares Change (YoY)	0.78%	1.53%	1.65%	0.41%	1.21%	0.43%
EPS (Basic)	1.70	1.26	1.08	0.45	0.69	-0.08
EPS (Diluted)	1.68	1.25	1.07	0.45	0.69	-0.08
EPS Growth	36.90%	16.82%	138.42%	-34.96%	-	-
Free Cash Flow	3,485	2,645	1,792	938	1,316	1,132
Free Cash Flow Per Share	2.34	1.78	1.22	0.65	0.92	0.80
Gross Margin	68.04%	68.41%	69.16%	68.44%	68.37%	67.30%
Operating Margin	18.33%	17.93%	16.97%	16.03%	15.34%	9.60%
Profit Margin	13.54%	11.06%	11.03%	5.06%	8.29%	-1.16%
Free Cash Flow Margin	18.84%	15.79%	12.58%	7.40%	11.07%	11.42%
EBITDA	4,705	4,271	3,613	3,169	2,917	2,075
EBITDA Margin	25.44%	25.50%	25.37%	24.99%	24.54%	20.93%
D&A For EBITDA	1,315	1,269	1,196	1,136	1,093	1,123
EBIT	3,390	3,002	2,417	2,033	1,824	952
EBIT Margin	18.33%	17.93%	16.97%	16.03%	15.34%	9.60%
Effective Tax Rate	16.73%	19.11%	19.80%	38.82%	3.34%	-

Updated Jul 23, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q